Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis

被引:62
作者
Ji, JD
Tassiulas, I
Park-Min, KH
Aydin, A
Mecklenbräuker, I
Tarakhovsky, A
Pricop, L
Salmon, JE
Ivashkiv, LB
机构
[1] Cornell Univ, Hosp Special Surg, Dept Med, New York, NY 10021 USA
[2] Cornell Univ, Weill Grad Sch Med Sci, Grad Program Immunol, New York, NY 10021 USA
[3] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA
关键词
interleukin; 10; Fc receptor; signal transduction; Jak-Stat; macrophage;
D O I
10.1084/jem.20021820
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-10 (IL-10) is a potent deactivator of myeloid cells that limits the intensity and duration of immune and inflammatory responses. The activity of IL-10 can be suppressed during inflammation, infection, or after allogeneic tissue transplantation. We investigated whether inflammatory factors suppress IL-10 activity at the level of signal transduction. Out of many factors tested, only ligation of Fc receptors by immune complexes inhibited IL-10 activation of the Jak-Stat signaling pathway. IL-10 signaling was suppressed in rheumatoid arthritis joint macrophages that are exposed to immune complexes in vivo. Activation of macrophages with interferon-gamma was required for Fc receptor-mediated suppression of IL-10 signaling, which resulted in diminished activation of IL-10-inducible genes and reversal of IL-10-dependent suppression of cytokine production. The mechanism of inhibition involved decreased cell surface IL-10 receptor expression and Jak1 activation and was dependent on protein kinase C delta. These results establish that IL-10 signaling is regulated during inflammation and identify Fc receptors and interferon-gamma as important regulators of IL-10 activity. Generation of macrophages refractory to IL-10 can contribute to pathogenesis of inflammatory and infectious diseases characterized by production of interferon-gamma and immune complexes.
引用
收藏
页码:1573 / 1583
页数:11
相关论文
共 70 条
[1]   Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways [J].
Ahmed, ST ;
Ivashkiv, LB .
JOURNAL OF IMMUNOLOGY, 2000, 165 (09) :5227-5237
[2]  
Avdiushko R, 2001, J LEUKOCYTE BIOL, V70, P624
[3]   HIGH-LEVELS OF INTERLEUKIN-10 PRODUCTION IN-VIVO ARE ASSOCIATED WITH TOLERANCE IN SCID PATIENTS TRANSPLANTED WITH HLA MISMATCHED HEMATOPOIETIC STEM-CELLS [J].
BACCHETTA, R ;
BIGLER, M ;
TOURAINE, JL ;
PARKMAN, R ;
TOVO, PA ;
ABRAMS, J ;
MALEFYT, RD ;
DEVRIES, JE ;
RONCAROLO, MG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :493-502
[4]   Fc-γRI-deficient mice show multiple alterations to inflammatory and immune responses [J].
Barnes, N ;
Gavin, AL ;
Tan, PS ;
Mottram, P ;
Koentgen, F ;
Hogarth, PM .
IMMUNITY, 2002, 16 (03) :379-389
[5]   INTERLEUKIN-10 IS A CENTRAL REGULATOR OF THE RESPONSE TO LPS IN MURINE MODELS OF ENDOTOXIC-SHOCK AND THE SHWARTZMAN REACTION BUT NOT ENDOTOXIN TOLERANCE [J].
BERG, DJ ;
KUHN, R ;
RAJEWSKY, K ;
MULLER, W ;
MENON, S ;
DAVIDSON, N ;
GRUNIG, G ;
RENNICK, D .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2339-2347
[6]   INTERLEUKIN-10 ADMINISTRATION DECREASES SURVIVAL IN MURINE RECIPIENTS OF MAJOR HISTOCOMPATIBILITY COMPLEX DISPARATE DONOR BONE-MARROW GRAFTS [J].
BLAZAR, BR ;
TAYLOR, PA ;
SMITH, S ;
VALLERA, DA .
BLOOD, 1995, 85 (03) :842-851
[7]   A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages [J].
Brightbill, HD ;
Plevy, SE ;
Modlin, RL ;
Smale, ST .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :1940-1951
[8]   Dual role of interleukin-10 in murine lyme disease: Regulation of arthritis severity and host defense [J].
Brown, JP ;
Zachary, JF ;
Teuscher, C ;
Weis, JJ ;
Wooten, RM .
INFECTION AND IMMUNITY, 1999, 67 (10) :5142-5150
[9]  
Cameron AJM, 2001, EUR J IMMUNOL, V31, P2718, DOI 10.1002/1521-4141(200109)31:9<2718::AID-IMMU2718>3.0.CO
[10]  
2-7